Active Implants

Company Overview

Snapshot

Founded in January 2004 by Sandra R. (Lewkowski) Steinberg and Amiram Steinberg, Active Implants operates with 11–50 employees. The company has raised a total of $101.13M across 7 funding rounds from 4 investors. In September 2019, Active Implants received FDA Breakthrough Device Designation for its NUsurface® Meniscus Implant.

Business overview

Active Implants develops orthopedic implant solutions designed to complement the natural biomechanics of the musculoskeletal system, enabling patients to maintain an active lifestyle. The company's core product, the NUsurface meniscus implant, addresses knee pain in patients with meniscal-deficient knees through a minimally invasive procedure that conserves bone. Additionally, its TriboFit hip system, consisting of acetabular components for hip joint reconstruction, received a CE mark in 2006 and is marketed internationally. Active Implants operates within the Health Tech & Life Sciences sector, focusing on medical devices and surgery.

Strategic signal

In September 2019, Active Implants received FDA Breakthrough Device Designation for its NUsurface Meniscus Implant. This designation signals significant regulatory validation and potential for accelerated market access, highlighting the implant's innovative approach to treating knee pain and its importance in the orthopedic medical device landscape.

Company Intelligence Q&A

What is the primary focus of Active Implants?

Active Implants primarily focuses on developing orthopedic implant solutions that complement the natural biomechanics of the musculoskeletal system, helping patients maintain an active lifestyle. Its main product is the NUsurface meniscus implant for knee pain.

When did Active Implants receive FDA Breakthrough Device Designation for its NUsurface Meniscus Implant?

Active Implants received FDA Breakthrough Device Designation for its NUsurface Meniscus Implant in September 2019.

What was a significant funding event for Active Implants?

In March 2017, Active Implants closed a tranche of its Series D financing, with LS Health Science Partners participating.

What is the status of Active Implants' TriboFit hip system?

The TriboFit hip system, consisting of acetabular components for hip joint reconstruction, received a CE mark in 2006 and is marketed outside the United States via a distribution agreement.